Manufacturers Life Insurance Company, The Castle Biosciences Inc Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Castle Biosciences Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 9,467 shares of CSTL stock, worth $194,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,467
Previous 9,920
4.57%
Holding current value
$194,452
Previous $282,000
10.64%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$62.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$37.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$36.9 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$29.5 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$20.5 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $540M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...